Literature DB >> 23250562

Clustered carbohydrates in synthetic vaccines.

Francesco Peri1.   

Abstract

Are there general rules to obtain efficient immunization against carbohydrate antigens? Thanks to technological advances in glycobiology and glycochemistry we entered a new era in which the rational design of carbohydrate vaccines has become an achievable goal. The aim of this Tutorial Review is to present the most recent accomplishments in the field of semi and fully synthetic carbohydrate vaccines against viruses, bacteria and cancer. It is also pointed out that the understanding of the chemical and biochemical processes related to immunization allows the modern chemist to rationally design carbohydrate vaccines with improved efficiency.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23250562      PMCID： PMC3654047          DOI： 10.1039/c2cs35422e

Source DB:  PubMed          Journal:  Chem Soc Rev        ISSN： 0306-0012            Impact factor:   54.564


  58 in total

1.  A synthetic lipid A mimetic modulates human TLR4 activity.

Authors:  Matteo Piazza; Valentina Calabrese; Gaetana Damore; Roberto Cighetti; Theresa Gioannini; Jerrold Weiss; Francesco Peri
Journal:  ChemMedChem       Date:  2011-12-02       Impact factor: 3.466

Review 2.  Chemoselective ligation in glycochemistry.

Authors:  Francesco Peri; Francesco Nicotra
Journal:  Chem Commun (Camb)       Date:  2003-11-14       Impact factor: 6.222

3.  Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates.

Authors:  Ravindra A De Silva; Qianli Wang; Tristan Chidley; Dananjaya K Appulage; Peter R Andreana
Journal:  J Am Chem Soc       Date:  2009-07-22       Impact factor: 15.419

Review 4.  Immunological mechanisms of vaccination.

Authors:  Bali Pulendran; Rafi Ahmed
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

Review 5.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

6.  Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.

Authors:  J P Tam
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  Synthesis of a single-molecule L-rhamnose-containing three-component vaccine and evaluation of antigenicity in the presence of anti-L-rhamnose antibodies.

Authors:  Sourav Sarkar; Steven A Lombardo; Danielle N Herner; Rommel S Talan; Katherine A Wall; Steven J Sucheck
Journal:  J Am Chem Soc       Date:  2010-11-16       Impact factor: 15.419

8.  Novel hyperbranched glycomimetics recognized by the human mannose receptor: quinic or shikimic acid derivatives as mannose bioisosteres.

Authors:  C Grandjean; G Angyalosi; E Loing; E Adriaenssens; O Melnyk; V Pancré; C Auriault; H Gras-Masse
Journal:  Chembiochem       Date:  2001-10-01       Impact factor: 3.164

9.  Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen.

Authors:  S Zhang; L A Walberg; S Ogata; S H Itzkowitz; R R Koganty; M Reddish; S S Gandhi; B M Longenecker; K O Lloyd; P O Livingston
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

10.  Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis.

Authors:  Hong Xin; Sebastian Dziadek; David R Bundle; Jim E Cutler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-25       Impact factor: 11.205
View more
  18 in total

1.  A peptide-free, liposome-based oligosaccharide vaccine, adjuvanted with a natural killer T cell antigen, generates robust antibody responses in vivo.

Authors:  S Deng; L Bai; R Reboulet; R Matthew; D A Engler; L Teyton; A Bendelac; P B Savage
Journal:  Chem Sci       Date:  2014-04       Impact factor: 9.825

2.  Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis.

Authors:  Hong Xin; Pati Glee; Abby Adams; Farhan Mohiuddin; Karen Eberle
Journal:  Vaccine       Date:  2019-03-28       Impact factor: 3.641

3.  Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.

Authors:  Guochao Liao; Zhifang Zhou; Zhongwu Guo
Journal:  Chem Commun (Camb)       Date:  2015-06-14       Impact factor: 6.222

4.  Two-step functionalization of oligosaccharides using glycosyl iodide and trimethylene oxide and its applications to multivalent glycoconjugates.

Authors:  Hsiao-Wu Hsieh; Ryan A Davis; Jessica A Hoch; Jacquelyn Gervay-Hague
Journal:  Chemistry       Date:  2014-04-08       Impact factor: 5.236

5.  Lipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.

Authors:  Suttipun Sungsuwan; Zhaojun Yin; Xuefei Huang
Journal:  ACS Appl Mater Interfaces       Date:  2015-08-03       Impact factor: 9.229

Review 6.  Synthesis and Glycosidation of Anomeric Halides: Evolution from Early Studies to Modern Methods of the 21st Century.

Authors:  Yashapal Singh; Scott A Geringer; Alexei V Demchenko
Journal:  Chem Rev       Date:  2022-06-08       Impact factor: 72.087

7.  6-O-Branched Oligo-β-glucan-Based Antifungal Glycoconjugate Vaccines.

Authors:  Guochao Liao; Zhifang Zhou; Jun Liao; Luning Zu; Qiuye Wu; Zhongwu Guo
Journal:  ACS Infect Dis       Date:  2015-12-30       Impact factor: 5.084

Review 8.  Recent advances in synthetic carbohydrate-based human immunodeficiency virus vaccines.

Authors:  Zhenyuan Wang; Chunjun Qin; Jing Hu; Xiaoqiang Guo; Jian Yin
Journal:  Virol Sin       Date:  2016-03-17       Impact factor: 4.327

9.  Synthesis and evaluation of monophosphoryl lipid A derivatives as fully synthetic self-adjuvanting glycoconjugate cancer vaccine carriers.

Authors:  Zhifang Zhou; Mohabul Mondal; Guochao Liao; Zhongwu Guo
Journal:  Org Biomol Chem       Date:  2014-04-14       Impact factor: 3.876

10.  Recognition of flavin mononucleotide, Haemophilus influenzae type b and its capsular polysaccharide vaccines by antibodies specific to D-ribitol-5-phosphate.

Authors:  G Ravi; Yeldur P Venkatesh
Journal:  Glycoconj J       Date:  2014-08-10       Impact factor: 2.916
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.